New Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$394K Hold
340
– – 0.09% 45
2026
Q2
$408K Buy
340
+14
+4% +$14.3K 0.09% 44
2026
Q1
$300K Hold
326
– – 0.07% 52
2025
Q4
$350K Hold
326
– – 0.09% 47
2025
Q3
$249K Buy
326
+40
+14% +$29.8K 0.07% 50
2025
Q2
$223K Buy
+286
New +$222K 0.06% 53

Other funds holding LLY

New Capital Management's LLY Position: Q3 2026 in Review

New Capital Management held its Eli Lilly (LLY) position steady in Q3 2026 at 340 shares worth $394K. The position accounts for 0.09% of the portfolio, ranked #45.

New Capital Management first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $408K in Q2 2026. 3,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • New Capital Management held 340 shares of Eli Lilly worth $394K as of Q3 2026.
  • New Capital Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.09% of New Capital Management's portfolio in Q3 2026, its #45 holding.
  • New Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • New Capital Management's Eli Lilly position peaked at $408K in Q2 2026.
  • 3,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on New Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.